Mental Health Clinics in Humboldt, IA Accepting Medicare
8 Mental Health Clinics found. Showing 1 - 8
 Humboldt County Memorial Hospital Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1000 15th St N, Humboldt, IA 50548 Phone: 515-332-4200 Fax: 515-332-4820 |
Unitypoint Health-berryhill Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1111 11th Ave N, Humboldt, IA 50548 Phone: 515-332-2623 Fax: 515-573-7898 |
Sail Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 724 Sumner Ave, Humboldt, IA 50548 Phone: 712-660-0575 |
Berryhill Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21 Taft St N, Humboldt, IA 50548 Phone: 515-955-7171 Fax: 515-573-7898 |
Unitypoint Health-berryhill Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1000 15th St N, Humboldt, IA 50548 Phone: 800-482-8305 Fax: 515-573-7898 |
Unitypoint Health-berryhill Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1000 15th St N, Humboldt, IA 50548 Phone: 800-482-8305 Fax: 515-573-7898 |
Berryhill Center For Mental Health Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 800 13th St S, Humboldt, IA 50548 Phone: 515-332-4104 Fax: 515-573-7898 |
Berryhill Center For Mental Health Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1050 15th St N, Humboldt, IA 50548 Phone: 515-332-7660 Fax: 515-332-7646 |
News Archive
Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
Findings may yield novel therapeutic strategies for late-stage breast cancer
Researchers from the Boston University School of Medicine (BUSM) have determined how the TGFβ-Smad signaling pathway, which is over activated in late-stage cancers, is responsible for the "epigenetic memory" that maintains unique patterns of regulatory DNA hypermethylation causing silencing of critical genes that facilitate breast cancer progression.
Heart and liver transplant recipients at higher risk of developing lung cancer: Researchers
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
Drug reaction breakthrough
The ‘data mining' research maximises the information extracted from existing drug safety data by cross-referencing much of the existing information on adverse drug reactions.
Political activist discusses Obamacare on Voice of Russia
In an exclusive interview with the Voice of Russia, political activist Karl Denninger discusses Obamacare, medical monopolies, and why Democrats are likely to lose the next midterm elections.
› Verified 4 days ago